Search research articles
Contact Us
Filters
Showing results (31-40 of 122) with videos related to
Page
of 13
Sort By:
Transplantation
|
January 28, 1999
Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group
B Nashan, S Light, I R Hardie, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
February 1, 1991
Coagulation disorder during liver transplantation
M Sato, B Nashan, B Ringe, et al.
Transplantation
|
September 26, 2000
Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group
J R Thistlethwaite, B Nashan, M Hall, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
June 3, 2000
Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis
H Ekberg, L Bäckman, G Tufveson, et al.
Deutsche Medizinische Wochenschrift (1946)
|
April 16, 1998
[State-of-the-art therapy for primary sclerosing cholangitis]
S Wanger, P N Meier, H Maschek, et al.
Deutsche Medizinische Wochenschrift (1946)
|
April 7, 1998
[The current diagnosis of primary sclerosing cholangitis]
S Wagner, H Maschek, P N Meier, et al.
Transplantation Proceedings
|
October 1, 1987
Fine specificity of a panel of antibodies against the TCR/CD3 complex
B Nashan, K Wonigeit, R Schwinzer, et al.
Transplantation Proceedings
|
August 1, 1989
Clinical usefulness of a semiquantitative scoring system for liver transplant aspiration cytology
H J Schlitt, B Nashan, B Ringe, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
January 1, 1995
Early intragraft inflammatory events of liver allografts leading to chronic rejection
I Lautenschlager, B Nashan, H J Schlitt, et al.
Clinical Transplants
|
October 20, 2000
CMV in kidney transplantation: a single center experience over 22 years
B Nashan, R Lück, V Kliem, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 122) with videos related to
Sort By:
Page
of 13
Transplantation
|
January 28, 1999
Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group
B Nashan, S Light, I R Hardie, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
February 1, 1991
Coagulation disorder during liver transplantation
M Sato, B Nashan, B Ringe, et al.
Transplantation
|
September 26, 2000
Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group
J R Thistlethwaite, B Nashan, M Hall, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
June 3, 2000
Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis
H Ekberg, L Bäckman, G Tufveson, et al.
Deutsche Medizinische Wochenschrift (1946)
|
April 16, 1998
[State-of-the-art therapy for primary sclerosing cholangitis]
S Wanger, P N Meier, H Maschek, et al.
Deutsche Medizinische Wochenschrift (1946)
|
April 7, 1998
[The current diagnosis of primary sclerosing cholangitis]
S Wagner, H Maschek, P N Meier, et al.
Transplantation Proceedings
|
October 1, 1987
Fine specificity of a panel of antibodies against the TCR/CD3 complex
B Nashan, K Wonigeit, R Schwinzer, et al.
Transplantation Proceedings
|
August 1, 1989
Clinical usefulness of a semiquantitative scoring system for liver transplant aspiration cytology
H J Schlitt, B Nashan, B Ringe, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
January 1, 1995
Early intragraft inflammatory events of liver allografts leading to chronic rejection
I Lautenschlager, B Nashan, H J Schlitt, et al.
Clinical Transplants
|
October 20, 2000
CMV in kidney transplantation: a single center experience over 22 years
B Nashan, R Lück, V Kliem, et al.
Page
of 13